This episode currently has no reviews.
Submit ReviewWarren Buffett’s Berkshire Hathaway slashing its positions in a number of big names. So Is the Oracle of Omaha’s recent moves a warning sign for where these stocks are heading? Plus The pill that’s getting easier to swallow… as Viking Therapeutics announces new data on its weight loss drug. The impact on the space, and why the stock reversed course from its initial jump.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review